Atatürk Üniversitesi Atatürk Üniversitesi
Ara
Yayınlara dön
Makale Tam Makale Uluslararası 2015

Clinical Utility of Hepatic-Perfusion Computerized Tomography in Living-Donor Liver Transplantation: A Preliminary Study

Abdulmecit Kantarcı, B. PIRIMOGLU, Gürkan ÖZTÜRK, Bülent AYDINLI, Hayri OĞUL, A. Okur, Y. KIZRAK, O. OZYIGIT, Mine ÇELİK

TRANSPLANTATION PROCEEDINGS Cilt 47 · Sayı 2 · ss. 399–407 · 01.03.2015
DOI ile aç

Özet

Background. Vascular complications are a primary diagnostic consideration in liver transplant recipients, with an overall incidence of 9%. Cross-sectional imaging techniques provide information regarding vascular structure and luminal patency but can not quantitatively assess hepatocyte damage in the liver graft parenchyma. Perfusion computerized tomography (CT) is a recently developed method that allows for quantitative evaluation of hemodynamic changes in tissue. Our objective was to evaluate the clinical utility of perfusion CT in assessing vascular complications during living-donor liver transplantation (LDLT).

Atıf için künye

Kantarcı, A., PIRIMOGLU, B., ÖZTÜRK, G., AYDINLI, B., OĞUL, H., Okur, A., KIZRAK, Y., OZYIGIT, O., & ÇELİK, M. (2015). Clinical Utility of Hepatic-Perfusion Computerized Tomography in Living-Donor Liver Transplantation: A Preliminary Study. TRANSPLANTATION PROCEEDINGS, 47(2), 399–407. https://doi.org/10.1016/j.transproceed.2014.11.038

BibTeX
@article{kantarci2015-230210,
  author = {Kantarcı, Abdulmecit and PIRIMOGLU, B. and ÖZTÜRK, Gürkan and AYDINLI, Bülent and OĞUL, Hayri and Okur, A. and KIZRAK, Y. and OZYIGIT, O. and ÇELİK, Mine},
  title = {Clinical Utility of Hepatic-Perfusion Computerized Tomography in Living-Donor Liver Transplantation: A Preliminary Study},
  journal = {TRANSPLANTATION PROCEEDINGS},
  year = {2015},
  volume = {47},
  number = {2},
  pages = {399--407},
  issn = {0041-1345},
  doi = {10.1016/j.transproceed.2014.11.038},
  url = {https://akademik.atauni.edu.tr/yayinlar/230210-clinical-utility-of-hepatic-perfusion-computerized-tomography-in-living-donor}
}